CPT1A and ovarian cancer: Consistent with our results, CPT1A expression is increased in tumor specimens of pancreatic ductal adenocarcinoma and ovarian cancer and is associated with chemotherapy resistance or poor survival, whereas CPT1A knockdown induces energy stress, cell-cycle arrest, and sensitivity to glucose deprivation in cancer cells or inhibits xenograft growth [57,58].